Angiotech buys Contour Threads developer for $40m
This article was originally published in Clinica
Executive Summary
Canadian company Angiotech Pharmaceuticals is expanding its speciality surgery division with the acquisition of Quill Medical, the developer of Contour Threads, a line of specialised sutures used in cosmetic and general surgical procedures.